Search research articles
Contact Us
Filters
Showing results (151-160 of 327) with videos related to
Page
of 33
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 2, 2011
Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma
Richard W Joseph, Ryan J Sullivan, Robyn Harrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2026
Lipid Nanoparticle-encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36γ Plus Durvalumab Induces an Immunostimulatory Effect Within the Tumor Microenvironment in Patients with Advanced Solid Tumors
Randy F Sweis, Georgina V Long, Adil Daud, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 31, 2018
Circulating BRAF<sup>V600E</sup> Levels Correlate with Treatment in Patients with Thyroid Carcinoma
Carrie C Lubitz, Tiannan Zhan, Viswanath Gunda, et al.
Science Advances
|
June 24, 2021
Rejection of benign melanocytic nevi by nevus-resident CD4<sup>+</sup> T cells
Erik B Schiferle, Se Yun Cheon, Seokjin Ham, et al.
Journal for Immunotherapy of Cancer
|
March 14, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy
Naiyer Rizvi, Foluso O Ademuyiwa, Z Alexander Cao, et al.
Nature Communications
|
October 16, 2021
Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma
Kuang Du, Shiyou Wei, Zhi Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2025
Circulating tumor DNA is prognostic of patient outcome and enables therapy monitoring in metastatic uveal melanoma
Egle Ramelyte, Julian Kött, Aleigha R Lawless, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
December 23, 2020
Thermal Ablation, Embolization, and Selective Internal Radiation Therapy Combined with Checkpoint Inhibitor Cancer Immunotherapy: Safety Analysis
Konstantin S Leppelmann, Meghan J Mooradian, Suvranu Ganguli, et al.
Cancer
|
March 1, 2014
Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors
Allison Ackerman, Oliver Klein, David F McDermott, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 22, 2022
Renin-angiotensin-aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors
Zsofia D Drobni, Olivier Michielin, Thiago Quinaglia, et al.
Page
of 33
Search research articles
Search
Showing results (151-160 of 327) with videos related to
Sort By:
Page
of 33
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 2, 2011
Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma
Richard W Joseph, Ryan J Sullivan, Robyn Harrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2026
Lipid Nanoparticle-encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36γ Plus Durvalumab Induces an Immunostimulatory Effect Within the Tumor Microenvironment in Patients with Advanced Solid Tumors
Randy F Sweis, Georgina V Long, Adil Daud, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 31, 2018
Circulating BRAF<sup>V600E</sup> Levels Correlate with Treatment in Patients with Thyroid Carcinoma
Carrie C Lubitz, Tiannan Zhan, Viswanath Gunda, et al.
Science Advances
|
June 24, 2021
Rejection of benign melanocytic nevi by nevus-resident CD4<sup>+</sup> T cells
Erik B Schiferle, Se Yun Cheon, Seokjin Ham, et al.
Journal for Immunotherapy of Cancer
|
March 14, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy
Naiyer Rizvi, Foluso O Ademuyiwa, Z Alexander Cao, et al.
Nature Communications
|
October 16, 2021
Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma
Kuang Du, Shiyou Wei, Zhi Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2025
Circulating tumor DNA is prognostic of patient outcome and enables therapy monitoring in metastatic uveal melanoma
Egle Ramelyte, Julian Kött, Aleigha R Lawless, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
December 23, 2020
Thermal Ablation, Embolization, and Selective Internal Radiation Therapy Combined with Checkpoint Inhibitor Cancer Immunotherapy: Safety Analysis
Konstantin S Leppelmann, Meghan J Mooradian, Suvranu Ganguli, et al.
Cancer
|
March 1, 2014
Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors
Allison Ackerman, Oliver Klein, David F McDermott, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 22, 2022
Renin-angiotensin-aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors
Zsofia D Drobni, Olivier Michielin, Thiago Quinaglia, et al.
Page
of 33